Why lung cancer doesn't respond well to immunotherapy | MIT News | Massachusetts Institute of Technology
MIT researchers discovered why the immune system mounts such a lackluster response to lung cancer, even after treatment with immunotherapy drugs: Bacteria naturally found in the lungs help create an environment that suppresses T-cell activation in the lymph nodes near the lungs.